Respiratory failure & ventilation

A new reservoir-based continuous positive airway pressure (CPAP) with low oxygen consumption: the Bag-CPAP

Crit CarePublished Bench-to-bedside study

Authors' conclusion

In vitro, Bag-CPAP exhibited the highest oxygen saving properties albeit had increased WOB. It was well accepted clinically and reduced dyspnea.

Study context

Population
Adults with acute respiratory failure in two hospitals in France (clinical part); bench testing of CPAP devicesclinical study
Participants
20 adults
Exposure
Bag-CPAP vs four CPAP devices and an ICU ventilator
  • Bag-CPAPn = 20
Outcome
Delivered FiO2 and oxygen consumption (bench); device-imposed WOB
Methodological detailsbench study and observational clinical study, two hospitals
  • Bench study and observational clinical study
  • Two hospitals

Main finding

As reported in the abstract

Bench performance
  • All six systems reached the minimal fraction of inspired oxygen (FiO2) target of 40%; four reached ≥80% FiO2 with positive end expiratory pressure (PEEP) in range
  • Device-delivered FiO2/consumed oxygen ratio highest with Bag-CPAP irrespective of FiO2 target

Observational data: associations, not effects.

Further findings

Clinical study: oxygen flow rate to reach high (>90%) and moderate (>50%) FiO2 with Bag-CPAP — Bag-CPAP
15 (IQR 15–16) L/min
  • Clinical study: oxygen flow rate to reach high (>90%) and moderate (>50%) FiO2 with Bag-CPAP: Bag-CPAP 8 (IQR 7–9) L/min
  • Clinical study: oxygen flow rate to reach high (>90%) and moderate (>50%) FiO2 with Bag-CPAP: 15 [15-16] L/min for FiO2 > 90%; 8 [7-9] L/min for FiO2 > 50%

Clinical study: dyspnea score and SpO2

Dyspnea score improved significantly after introduction of Bag-CPAP, and SpO2 increased

Safety

Device-imposed work of breathing (WOB) (bench) and tolerance (clinical)

WOB induced by the device higher with Bag-CPAP
Bag-CPAP well tolerated clinically

Original publication

A new reservoir-based CPAP with low oxygen consumption: the Bag-CPAP. Crit Care. Published 4 July 2023. doi:10.1186/s13054-023-04542-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.